Tuhin Virmani

Associate Professor

UAMS

Also affiliated: Washington University in St. Louis (2011); Columbia University Irving Medical Center (2013); University of Arkansas Medical Center (2019–2022); Neurology, Inc (2021); Columbia University (2012–2016); The University of Texas Southwestern Medical Center (2003–2007)

Neurology, College of Medicine

21 h-index 87 pubs 1,660 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Tuhin Virmani's research focuses on the neurological mechanisms underlying movement disorders, particularly Parkinson disease. His work has explored the physiological processes of neuronal communication, including the role of neurotransmitters at the synapse. Dr. Virmani investigated the clinicopathological characteristics of freezing of gait in Parkinson disease through autopsy-confirmed studies. He has also examined the interaction between dietary protein and levodopa in motor fluctuations experienced by Parkinson disease patients.

His early research contributed to understanding synaptic vesicle recycling and the cell-autonomous roles of specific proteins in synapse establishment. More recently, Dr. Virmani has investigated the application of machine learning methods for the identification of Parkinson disease through voice sample analysis. He maintains an active laboratory and has a significant publication record, with an h-index of 21 and over 1,655 citations. Dr. Virmani collaborates with several researchers at the University of Arkansas for Medical Sciences, including Lakshmi Pillai, Aliyah Glover, Linda Larson-Prior, and Aaron S. Kemp.

Research Overview

Dr. Virmani completed his medical training at UT Southwestern Medical School in Dallas where he was in the Medical Scientist Training Program (MSTP) receiving a combined M.D/Ph.D degree. His research in basic neuroscience explored the physiologic mechanisms by which neurons in the brain communicate with one other using chemical neurotransmitters at the synapse. He then went on to pursue a residency in Neurology at Washington University in St. Louis where he developed an interest in Movement Disorders. This lead to a two year combined clinical-research fellowship in Movement Disorders under the guidance of Dr. Stanley Fahn and other members of the Center for Parkinson Disease and other Movement Disorders at Columbia University Medical Center in New York. While at Columbia University, Dr. Virmani became interested in the principles underlying the phenomenon of freezing of gait in Parkinson disease and he undertook a clinicopathologic study under the mentorship of Dr. Fahn and Dr. Jean-Paul Vonsattel (Department of Pathology). He also worked with Dr. Fahn to start a clinical trial using a novel motor-neuronotrophic factor for potential neuroprotection in Parkinson disease. This trial is currently underway. In addition to his clinical duties as the Director of the Movement Disorders program at UAMS, Dr. Virmani plans to continue to develop his research interests with the establishment of a gait lab and eventual participation in national clinical research trials.

Metrics

h-index: 21
Publications: 87
Citations: 1,660

Positions

Associate Professor, Director Movement Disorders Neurology Program 2019–present

University of Arkansas for Medical Sciences Neurology ORCID
Associate Professor publications 2014–2026

University of Arkansas for Medical Sciences Neurology, College of Medicine Institutional directory
Assistant Professor, Director Movement Disorders Program 2013–2019

University of Arkansas for Medical Sciences Neurology ORCID

Selected Publications

Author Correction: A machine learning method to process voice samples for identification of Parkinson’s disease (2026)

Scientific Reports DOI OpenAlex
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention (2026)

Current Opinion in Neurology DOI OpenAlex
Use of a Binary Logistic Regression Model to Categorize People with Parkinson’s Disease as Freezers or Non-freezers (P9-17.006) (2026)

Neurology DOI OpenAlex
Time to Freeze: Development of OFF ‐ and OFFON ‐State Freezing of Gait in Parkinson's Disease (2026)

Movement Disorders Clinical Practice DOI OpenAlex
Voice and Speech in Atypical Parkinsonian Disorders (2026)

Movement Disorders Clinical Practice 2 citations DOI OpenAlex
An updated definition of freezing of gait (2026)

Nature Reviews Neurology 27 citations DOI OpenAlex
Pearls & Oy-sters: Hereditary Spastic Paraplegia Type 15 Presenting as Juvenile Onset Levodopa-Responsive Parkinsonism (2026)

Neurology DOI OpenAlex
A qualitative approach to extract diagnostic patterns of cognitive impairment in Parkinson’s disease (2026)

Scientific Reports DOI OpenAlex
Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease (2025)

Annals of Clinical and Translational Neurology DOI OpenAlex
Exploring the relationship between orthostatic hypotension and gait in people with Parkinson’s disease (2025)

Clinical Autonomic Research 2 citations DOI OpenAlex
Levodopa influence on turning dynamics in people with Parkinson’s disease (2025)

Scientific Reports 4 citations DOI OpenAlex
Longitudinal Monitoring of Digitized Cursive Writing in People with Parkinson’s Disease Shows Increased Variability in Absolute Jerk and Decreased Writing Duration in Those with Freezing of Gait (P9-5.019) (2025)

Neurology DOI OpenAlex
Pre-trained convolutional neural networks identify Parkinson’s disease from spectrogram images of voice samples (2025)

Scientific Reports 23 citations DOI OpenAlex
Pre-trained Convolutional Neural Networks Identify Parkinson’s Disease from Spectrogram Images of Voice Samples (2024)

Research Square 1 citation DOI OpenAlex
Levodopa influence on turning dynamics in people with Parkinson’s disease (2024)

Research Square DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Gut-microbiota-metabolite cross-talk in neuropsychiatric symptoms of Parkinson's Disease UAMS Principal Investigator
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine NIH Co-Investigator
Gait Physiology as a non-invasive biomarker for Freezing of Gait in Parkinson’s Disease UAMS Principal Investigator
Machine Learning Approaches for Remote Pathological Speech Assessment for Parkinson’s Disease NSF/EPSCoR Co-Investigator
Comparison of different health care delivery methods in a rural underserved population of People with Parkinson’s Disease NIH/NCATS Principal Investigator
Utilization of a Neuroinformatics Research Platform (ARIES) to Develop Quantitative Tools for Clinical Assessment and Treatment of Parkinson’s Disease Patients in Rural Arkansas NIH/NCATS UL1TR003107 Principal Investigator
Gamified quantification of normal and pathological movement using 2D and Virtual Reality and Haptic sensing for therapeutic efficacy and disease progression in movement disorders NIH/NCATS Co-Investigator
ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas Principal Investigator